Home

Walgreens Boots Alliance, Inc. - Common Stock (WBA)

10.69
-0.09 (-0.83%)
NASDAQ · Last Trade: Apr 11th, 3:09 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
DoorDash Gets In On Robot Deliveries With Uber Eats, Grubhub As Food Apps Eye Efficiencystocktwits.com
The rollout follows a pilot program with Wolt, DoorDash’s international arm, in Helsinki, Finland, where Coco robots have been making deliveries since early this year.
Via Stocktwits · April 10, 2025
Seeking Income? 3 High Yield Stocks Worth A Looktalkmarkets.com
Everybody loves dividends as they provide a passive income stream and more than one way to reap a return from an investment. Dividend-paying stocks are generally less volatile by nature, another positive benefit in the current landscape.
Via Talk Markets · April 10, 2025
US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expertbenzinga.com
U.S. stock futures were volatile on Wednesday after the equities reversed gains on Tuesday following Donald Trump's 104% tariff on China.
Via Benzinga · April 9, 2025
Dow Dips Over 300 Points As US-China Trade Tensions Escalate: Apple, Tesla, Nvidia, Amazon Decline, Greed Index Remains In 'Extreme Fear' Zonebenzinga.com
Apple, Tesla, Amazon, and Nvidia shares dropped. Walgreens reported good earnings. All sectors of S&P 500 closed in the red.
Via Benzinga · April 9, 2025
Walgreens Boots Alliance Earnings Previewbenzinga.com
Via Benzinga · April 7, 2025
Crude Oil Gains 1%; Walgreens Posts Upbeat Earningsbenzinga.com
Via Benzinga · April 8, 2025
Walgreens Boots Alliance Q2 Profit Falls 47.5%, Suspends Guidance On Pending Private Equity Dealbenzinga.com
Walgreens reports Q2 revenue beat with strong pharmacy growth, but earnings fall amid weaker retail sales and U.S. Healthcare shifts.
Via Benzinga · April 8, 2025
Walgreens’s (NASDAQ:WBA) Q1: Beats On Revenue
Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 4.1% year on year to $38.59 billion. Its non-GAAP profit of $0.63 per share was 21% above analysts’ consensus estimates.
Via StockStory · April 8, 2025
Wall Street Eyes Recovery As S&P 500, Nasdaq Futures Rise After Trump's Tariff-Driven Selloff Wipes Out $9 Trillion In Six Weeksbenzinga.com
U.S. stock futures rose on Tuesday following a volatile day of trading on Monday that led the indices to close on a mixed note.
Via Benzinga · April 8, 2025
Earnings Scheduled For April 8, 2025benzinga.com
Via Benzinga · April 8, 2025
Dow Falls For 3rd Session Amid Trump's Tariff Threats As Apple, Tesla Decline: Greed Index Remains In 'Extreme Fear' Zonebenzinga.com
Via Benzinga · April 8, 2025
Top Wall Street Forecasters Revamp Walgreens Price Expectations Ahead Of Q2 Earningsbenzinga.com
Via Benzinga · April 8, 2025
Walgreens, RPM International And 3 Stocks To Watch Heading Into Tuesdaybenzinga.com
Via Benzinga · April 8, 2025
Walgreens Earnings: What To Look For From WBA
Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) will be reporting results tomorrow before market open. Here’s what to look for.
Via StockStory · April 7, 2025
How To Earn $500 A Month From Walgreens Stock Ahead Of Q2 Earningsbenzinga.com
Via Benzinga · April 7, 2025
Blackrock CEO Larry Fink Says Investors Are More Anxious About the Economy Than They've Been in Recent History. These 3 Stocks Will Help Calm Your Nerves.fool.com
Via The Motley Fool · April 3, 2025
Consumer Retail Stocks Q4 Recap: Benchmarking Walgreens (NASDAQ:WBA)
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the consumer retail industry, including Walgreens (NASDAQ:WBA) and its peers.
Via StockStory · April 3, 2025
Wall Street's Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 6% Dividend Yieldsbenzinga.com
Via Benzinga · April 2, 2025
3 Investments That Cut You a Check Each Monthfool.com
Realty Income, Main Street Capital, and the JPMorgan Equity Premium Income ETF deliver reliable monthly dividends for conservative income investors.
Via The Motley Fool · April 2, 2025
Hims & Hers Adds Eli Lilly's Zepbound To Weight-Loss Offerings: Retail Excited Despite BofA Seeing 'Immaterial' Sales Impactstocktwits.com
According to Bloomberg, a monthly prescription of Zepbound via Hims' platform would cost $1,899 — $800 more than Lilly's list price for the drug.
Via Stocktwits · April 1, 2025
Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?fool.com
High dividend yields can signal either financial strength or serious trouble. Here's what you need to know about today's top S&P 500 dividend payers.
Via The Motley Fool · March 28, 2025
Should You Buy Walgreens Boots Alliance Stock Before It Goes Private?fool.com
Via The Motley Fool · March 27, 2025
Walgreens (WBA): Buy, Sell, or Hold Post Q4 Earnings?
Walgreens has had an impressive run over the past six months. While the S&P 500 has been flat, the stock has returned 22.7% and now trades at $11.12. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Via StockStory · March 27, 2025
Wingstop, Walgreens, and Dollar General: Why I Prefer Realty Income Stock to All 3fool.com
Via The Motley Fool · March 25, 2025
3 Once-Promising Growth Stocks That Are Down 40% Since the 2020 Crash -- Can Any of Them Recover?fool.com
Via The Motley Fool · March 20, 2025